Poly (ADP-Ribose) Polymerase Inhibitor
specificA substance that blocks an enzyme involved in many functions of the cell, including the repair of DNA damage. DNA damage may be caused by normal cell actions, UV light, some anticancer drugs, and radiation used to treat cancer. It may cause cancer cells to die. It is a type of targeted therapy.
6
Centers
0
Active Trials
$7M
Cancer Funding
Top Centers for Poly (ADP-Ribose) Polymerase Inhibitor(6)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | UCSF Helen Diller Family Comprehensive Cancer CenterSan Francisco, CA NCI Comprehensive High-Volume Research Center | 72.9 |
| 2 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 67.1 |
| 3 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 61.3 |
| 4 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 55.4 |
| 5 | Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive Active Research Program | 49.6 |
| 6 | UMass Memorial Health Cancer CenterWorcester, MA Active Research Program | 43.8 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →